NFKB1 and cancer: Many of these TME-derived signals are themselves dependent on NF-κB activation in non-malignant cells, thus fueling a positive feedback cycle that perpetuates cancer-cell survival, tumor-based inflammation, metastatic dissemination, and cancer immune evasion [6,7,20,21,22,23].